Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study will be to evaluate whether a bivalent oral polio vaccine (bOPV) manufactured by Beijing Bio-Institute Biological Products Co., Ltd (BBIBP) has a similar immunogenicity profile to a WHO prequalified bOPV.
Epistemonikos ID: 8cb3d84c498cf1e124b6401d97021d1071fcac66
First added on: May 12, 2024